Nvidia’s Rough Week… And Why Users Start & Stop GLP-1 Drugs 1/31/25
CNBC's "Fast Money"
00:00
The Economics of GLP-1 Drugs
This chapter examines the intricate relationship between income levels, medication adherence, and the costs associated with GLP-1 drugs for managing type 2 diabetes. It discusses recent pharmaceutical developments, competition between major companies, and market dynamics, while also highlighting the need for improved access and strategies to enhance patient retention across varying income brackets.
Play episode from 31:21
Transcript
